Postbiotic Activity of Enterococcus asini EAs 1/11D27 Strain Originating from the Norik of Muráň Breed
Keywords:
Equine, Norik of Muráň breed, postbiotic, antimicrobial effect, Enterococcus asiniAbstract
The Norik of Muráň breed is a Slovak horse breed mainly intended for forestry and agriculture-related work. It is also a unique type among the cold-blooded horse breeds. In general, the microbiota influences animal health status. However, limited information regarding the microbiota of this horse species is available. Similarly, few aspects are known about the species Enterococcus asini bacteriocin (postbiotic) potential. Therefore, this study investigated the E. asini strain EAs 1/11D27, isolated from mucosal samples obtained from horses, along with the evaluation of its molecular characteristics and bacteriocin (postbiotic) activity. Taxonomic allocation of the strain EAs 1/11/D27 was confirmed using the sequencing method, reaching 99.86% similarity (match) with the nucleotide sequence of the strain E. asini NR113929.1. E. asini EAs 1/11D27 has been assigned the GenBank accession number (AN) MN822908. This strain is hemolysis-negative, deoxyribonuclease-negative, and gelatinase-negative. EAs 1/11D27 lacks genes encoding for virulence factors such as gelatinase, enterococcal surface protein, adhesins, hyaluronidase, and aggregation substance. It does not produce damaging enzymes and is susceptible to antibiotics. Additionally, it produces bacteriocin-like substances with inhibitory activity against 165 out of 170 indicator bacteria tested (97%). The highest inhibitory potential was recorded against staphylococci (88), enterococci (57), lactococci (7), and streptococci (4/8). The growth of 9 out of 10 Gram-negative strains was also inhibited. These results suggest a valuable postbiotic potential of the studied bacteriocin substance, and further studies are needed to establish its applications in horses.
References
Halo M, Mlyneková E, Horná M, Ivančíková M, Hrdá A. Evaluation of genetic variability of the breed Norik of Muran according to pedigree information. Czech Journal of Animal Science 2018;63:195–200. https://doi.org/10.17221/20/2017-cjas.
Pošivák J, Styková E, Novotný F, Valocký I, Noskovičová J, Tučková M, et al. Comparison of some biochemical and mineral indices among Norik breed Muráň Plain type and Hucul breed mares. Acta Veterinaria Brno 2015;84:113–7. https://doi.org/10.2754/avb201584020113.
Al Jassim RAM, Andrews FM. The bacterial community of the horse gastrointestinal tract and its relation to fermentative acidosis, laminitis, colic, and stomach ulcers. Veterinary Clinics of North America: Equine Practice 2009;25:199–215. https://doi.org/10.1016/j.cveq.2009.04.005.
Friedrich MJ. Microbiome project seeks to understand human body's microscopic residents. JAMA 2008;300:777. https://doi.org/10.1001/jama.300.7.777.
Wobeser BK. Skin diseases in horses. Veterinary Clinics of North America: Equine Practice 2015;31:359–76. https://doi.org/10.1016/j.cveq.2015.04.007.
Schoster A, Weese JS, Guardabassi L. Probiotic use in horses - what is the evidence for their clinical efficacy? Journal of Veterinary Internal Medicine 2014;28:1640–52. https://doi.org/10.1111/jvim.12451.
Martín R, Langella P. Emerging health concepts in the probiotics field: streamlining the definitions. Frontiers in Microbiology 2019;10:1047. https://doi.org/10.3389/fmicb.2019.01047.
Nataraj BH, Ali SA, Behare PV, Yadav H. Postbiotics-parabiotics: the new horizons in microbial biotherapy and functional foods. Microbial Cell Factories 2020;19:168. https://doi.org/10.1186/s12934-020-01426-w.
Franz CMAP, Huch M, Abriouel H, Holzapfel W, Gálvez A. Enterococci as probiotics and their implications in food safety. International Journal of Food Microbiology 2011;151:125–40. https://doi.org/10.1016/j.ijfoodmicro.2011.08.014.
Franz CMAP, Van Belkum MJ, Holzapfel WH, Abriouel H, Gálvez A. Diversity of enterococcal bacteriocins and their grouping in a new classification scheme. FEMS Microbiology Reviews 2007;31:293–310. https://doi.org/10.1111/j.1574-6976.2007.00064.x.
Ness IF, Diep DB, Ike Y. Enterococcal bacteriocins and antimicrobial proteins that contribute to niche control. In: Gilmore MS, Clewell DB, Ike Y, Shankar N, editors. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection, Boston: Massachusetts Eye and Ear Infirmary; 2014.
Focková V, Styková E, Simonová MP, Maďar M, Kačírová J, Lauková A. Horses as a source of bioactive fecal strains Enterococcus mundtii. Veterinary Research Communications 2022;46:739–47. https://doi.org/10.1007/s11259-022-09893-9.
Lauková A, Micenková L, Kubašová I, Bino E, Kandričáková A, Plachá I, et al. Microbiota, phagocytic activity, biochemical parameters and parasite control in Horses with Application of autochthonous, bacteriocin-producing, probiotic Strain Enterococcus faecium EF 412. Probiotics and Antimicrobial Proteins 2022;15:139–48. https://doi.org/10.1007/s12602-022-09918-4.
Lauková A, Styková E, Kubašová I, Gancarčíková S, Plachá I, Mudroňová D, et al. Enterocin M and its beneficial effects in horses—a pilot experiment. Probiotics and Antimicrobial Proteins 2018;10:420–6. https://doi.org/10.1007/s12602-018-9390-2.
Lauková A, Styková E, Focková V, Maďar M. Enterococcus moraviensis EMo 1-1Nik of horse origin:characteristics and potential bacteriocin-producing strain. Veterinary Research Communications 2023;47:1471–8. https://doi.org/10.1007/s11259-023-10101-5.
de Vaux A, Laguerre G, Divies C, Prevost H. Enterococcus asini sp. nov. isolated from the caecum of donkeys (Equus asinus). International Journal of Systematic Bacteriology 1998;48:383–7. https://doi.org/10.1099/00207713-48-2-383.
De Vuyst L, Callewaert R, Pot B. Characterization of the antagonistic activity of Lactobacillus amylovorus DCE 471 and large scale isolation of its bacteriocin Amylovorin L471. Systematic and Applied Microbiology 1996;19:9–20. https://doi.org/10.1016/s0723-2020(96)80003-8.
Lauková A, Kandričáková A, Bino E. Biofilm formation ability in streptococci causing acute otitis media in children and their treatment with lantibiotic Gallidermin. Journal of Medicine and Public Health 2021;2:1019.
Semedo-Lemsaddek T, Nóbrega CS, Ribeiro T, Pedroso NM, Sales-Luís T, Lemsaddek A, et al. Virulence traits and antibiotic resistance among enterococci isolated from Eurasian otter (Lutra lutra). Veterinary Microbiology 2013;163:378–82. https://doi.org/10.1016/j.vetmic.2012.12.032.
Lauková A, Pogány Simonová M, Focková V, Tomáška M, Drončovský M, Vargová M, et al. Slovak raw goat milk as a source of variable, biofilm‐forming staphylococci, and their susceptibility to lantibiotic bacteriocins. JSFA Reports 2022;2:40–7. https://doi.org/10.1002/jsf2.27.
Kubašová I, Strompfová V, Lauková A. Safety assessment of commensal enterococci from dogs. Folia Microbiologica 2017;62:491–8. https://doi.org/10.1007/s12223-017-0521-z.
Lauková A, Styková E, Kubašová I, Strompfová V, Gancarčíková S, Plachá I, et al. Enterocin M-producing Enterococcus faecium CCM 8558 demonstrating probiotic properties in horses. Probiotics and Antimicrobial Proteins 2020;12:1555–61. https://doi.org/10.1007/s12602-020-09655-6.
Kahlmeter G, Brown DFJ, Goldstein FW, MacGowan AP, Mouton JW, Odenholt I, et al. European Committee on Antimicrobial Susceptibility Testing (EUCAST) technical notes on antimicrobial susceptibility testing. Clinical Microbiology and Infection 2006;12:501–3. https://doi.org/10.1111/j.1469-0691.2006.01454.x
Focková V. Experimental application of Mundticin-like substance EM 41/3 in horses of the breed Norik from Muráň. Proceedings of the International Conference Probiotics, Prebiotics and Health in Bratislava, 2023, p. 44.
Kubašová I, Diep DB, Ovchinnikov KV, Lauková A, Strompfová V. Bacteriocin production and distribution of bacteriocin-encoding genes in enterococci from dogs. International Journal of Antimicrobial Agents 2020;55:105859. https://doi.org/10.1016/j.ijantimicag.2019.11.016.
Liang B, Xing D. The current and future perspectives of postbiotics. Probiotics and Antimicrobial Proteins 2023;15:1626–43. https://doi.org/10.1007/s12602-023-10045-x.
Mosca A, Abreu Y Abreu AT, Gwee KA, Ianiro G, Tack J, Nguyen TVH, et al. The clinical evidence for postbiotics as microbial therapeutics. Gut Microbes 2022;14:2117508. https://doi.org/10.1080/19490976.2022.2117508.
Xie W, Zhong Y-S, Li X-J, Kang Y-K, Peng Q-Y, Ying H-Z. Postbiotics in colorectal cancer: intervention mechanisms and perspectives. Frontiers in Microbiology 2024;15:1360225. https://doi.org/10.3389/fmicb.2024.1360225.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Andrea Lauková, Eva Styková, Valentína Focková, Aleksandra Troscianczyk, Marián Maďar
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
